169 related articles for article (PubMed ID: 17876148)
41. [The chemotherapy with mFOLFOX6 for advanced colon cancer was effective for gastric cancer - a case report].
Shimoishi K; Muto Y; Asakage M; Yamada Y
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1127-30. PubMed ID: 22790053
[TBL] [Abstract][Full Text] [Related]
42. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
[TBL] [Abstract][Full Text] [Related]
43. [Clinical development of chemotherapy for advanced gastric cancer].
Sato A; Nakamachi M
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1461-6. PubMed ID: 18799898
[TBL] [Abstract][Full Text] [Related]
44. [The third report from Sapporo Tsukisamu Hospital--chemotherapy for patients with advanced gastric cancer (peritoneal dissemination, peritonitis carcinomatosa)].
Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1405-11. PubMed ID: 17876138
[TBL] [Abstract][Full Text] [Related]
45. [Recurrent gastric cancer treated with fourth-line chemotherapy consisting of capecitabine and cisplatin leading to partial response].
Makari Y; Iijima S; Doi T; Hoshi M; Oshima S; Ikeda K; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2265-7. PubMed ID: 24394080
[TBL] [Abstract][Full Text] [Related]
46. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP].
Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248
[TBL] [Abstract][Full Text] [Related]
47. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
48. [5-FU/l-LV therapy is useful for hemodialysis patients with advanced gastric cancer].
Saito Y; Shimada K; Ohno Y; Toshima H; Kobayashi K; Miyashita K; Tsuchiya S; Takinishi Y; Miyokawa A; Itoh T; Sakashita A
Gan To Kagaku Ryoho; 2011 Mar; 38(3):449-51. PubMed ID: 21403452
[TBL] [Abstract][Full Text] [Related]
49. [A case of advanced gastric cancer with peritoneal dissemination effectively treated with fourth-line chemotherapy of S-1 alone].
Murakami S; Samejima R; Sumi K; Hidaka K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):915-8. PubMed ID: 17565256
[TBL] [Abstract][Full Text] [Related]
50. The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Kim JW; Im SA; Kim M; Cha Y; Lee KH; Keam B; Kim MA; Han SW; Oh DY; Kim TY; Kim WH; Bang YJ
Anticancer Res; 2012 Apr; 32(4):1547-53. PubMed ID: 22493400
[TBL] [Abstract][Full Text] [Related]
51. [Standard chemotherapy for gastrointestinal malignancies based on evidence].
Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takada N
Gan To Kagaku Ryoho; 2000 Feb; 27(2):166-76. PubMed ID: 10700886
[TBL] [Abstract][Full Text] [Related]
52. Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
Choi IS; Choi M; Lee JH; Kim JH; Suh KJ; Lee JY; Kang B; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
PLoS One; 2018; 13(6):e0198544. PubMed ID: 29879177
[TBL] [Abstract][Full Text] [Related]
53. [Improving the anti-tumor activity of 5-fluorouracil by methotrexate].
Konishi T; Noie T; Abe T; Agawa S; Furushima K; Ito K; Mafune K; Makuuchi M; Teruya M; Nouchi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):431-9. PubMed ID: 10097739
[TBL] [Abstract][Full Text] [Related]
54. Clinical pharmacokinetics of oxaliplatin in a hemodialysis patient with advanced gastric cancer.
Maruta M; Miyoshi T; Matsuo N; Yamashina T; Irie K; Tsuruta M; Tsukada H; Tsuruyama M; Nagano M; Hiraki Y
J Chemother; 2021 Feb; 33(1):51-55. PubMed ID: 32066346
[TBL] [Abstract][Full Text] [Related]
55. Interstitial lung disease associated with FOLFOX chemotherapy.
Lim JH; Kim H; Choi WG; Lee MH
J Cancer Res Ther; 2010; 6(4):546-8. PubMed ID: 21358098
[TBL] [Abstract][Full Text] [Related]
56. [Comparison the standard therapies of gastric cancer in Japan with those in the West].
Sasaki E; Maeda Y; Sasaki T
Gan To Kagaku Ryoho; 2007 May; 34(5):700-4. PubMed ID: 17496440
[TBL] [Abstract][Full Text] [Related]
57. Successful twin pregnancy outcome after in utero exposure to FOLFOX for metastatic colon cancer: a case report and review of the literature.
Jeppesen JB; Østerlind K
Clin Colorectal Cancer; 2011 Dec; 10(4):348-52. PubMed ID: 21803658
[TBL] [Abstract][Full Text] [Related]
58. Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.
Park JM; Chi KC
World J Surg Oncol; 2010 Dec; 8():109. PubMed ID: 21167074
[TBL] [Abstract][Full Text] [Related]
59. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer.
Argyriou AA; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP; Chroni E
Acta Oncol; 2007; 46(8):1131-7. PubMed ID: 17851880
[TBL] [Abstract][Full Text] [Related]
60. [Two cases of inoperable gastric cancer successively treated with TS-1+CDDP as neoadjuvant chemotherapy].
Takada J; Katsuki Y; Hamada H; Tsuji Y
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1897-9. PubMed ID: 17212140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
